Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
09/2003
09/25/2003US20030180836 Secreted and transmembrane polypeptides and nucleic acids encoding the same
09/25/2003US20030180818 Isolated nucleic acid molecules encoding human peptidoglycan recognition protein-related proteins, referred to PGRP-K (keratinocytes), PGRP-W (wound healing) and PGRP-C (chondrosarcoma)
09/25/2003US20030180816 Method to provide bacterial ghosts provided with antigens
09/25/2003US20030180813 Method of screening remedy for diabetes
09/25/2003US20030180812 Novel human leucine-rich repeat containing protein expressed predominately in bone marrow, HLRRBM1
09/25/2003US20030180810 For diagnosis, prevention, and treatment of reproductive disorders, Alzheimer's disease, cancer, immunological disorders, and diabetes
09/25/2003US20030180805 Methods and compositions for derepression of IAP-inhibited caspase
09/25/2003US20030180799 Antibodies against plasma cells
09/25/2003US20030180798 Analyzing second messenger sigalling activity; drug screening
09/25/2003US20030180796 Fibroblast/epidermal growth factors; PRO polypeptides
09/25/2003US20030180795 Monoclonal/humanized antibodies; fusion proteins; PRO polypeptides
09/25/2003US20030180794 Secreted and transmembrane polypeptides and nucleic acids encoding the same
09/25/2003US20030180793 Monoclonal/humanized antibodies; fusion proteins; PRO polypeptides
09/25/2003US20030180792 Fusion proteins; PRO polypeptides; fibroblast/nerve growth factor receptors
09/25/2003US20030180785 Polynucleotide molecules encoding Neospora proteins
09/25/2003US20030180784 For modulating the growth and/or differentiation of (endothelial) cells; drug screening
09/25/2003US20030180778 UDP-N-acetylglucosamine: galactose-beta1,3-N-acetylgalactosamine-alpha-R/ (GlcNAc to GalNAc) beta1,6-N-acetylglucosaminyltransferase, C2GnT3
09/25/2003US20030180756 Nucleic acids encoding RNAs targeting specific genes (in eukaryotic cells) and thereby inhibiting expression of these genes and expression of abnormal mutated protein
09/25/2003US20030180755 Pharmaceutical compositions in particulate form
09/25/2003US20030180753 Full length human hcn1ih channel subunit and variants
09/25/2003US20030180752 Type 2 cytokine receptor and nucleic acids encoding same
09/25/2003US20030180750 Treatment of cancer and neurological diseases
09/25/2003US20030180745 Novel nucleic acids and polypeptides
09/25/2003US20030180739 Culturing a cell in the presence or absence of the compound, assaying the cell for expression or activity of gene(s), detecting the compound when expression of the genes is lower in the presence of the compound than in the absence
09/25/2003US20030180734 Peptide nucleic acids
09/25/2003US20030180728 Differentially regulated in breast cancer
09/25/2003US20030180726 Compositions and methods relating to ovarian specific genes and proteins
09/25/2003US20030180722 An isolated polynucleotide containing a nucleotide sequence with a specific sequence, translated protein coding protion, mature protein coding protion, extracellular portion or the active domain, codes a polypeptide
09/25/2003US20030180719 Human cellular protein gastrointestinal glutathione peroxidase as target for medical intervention against hepatitis C virus infections
09/25/2003US20030180416 Carbohydrate oxidase and use thereof in baking
09/25/2003US20030180405 For cosmstics, drugs; antiinflamamtory agents; oxidation resistance
09/25/2003US20030180404 Methods of treating clinical diseases with isoflavones
09/25/2003US20030180365 Preparation containing an oxygen carrier for regeneration of the skin in the case of oxygen deficiency
09/25/2003US20030180364 Catheter injectable depot compositions and uses thereof
09/25/2003US20030180363 Biodegradation polymer; liquid phase polyoxyethylene glycol
09/25/2003US20030180362 Multi-stage oral drug controlled-release system
09/25/2003US20030180359 Controlled release
09/25/2003US20030180355 Combination therapy for hypertension
09/25/2003US20030180348 Transcellular drug delivery system
09/25/2003US20030180339 Topical treatment of skin
09/25/2003US20030180332 Novel pharmaceutical composition
09/25/2003US20030180328 Forming vaccines; analyzing hemagglutinin, calibration
09/25/2003US20030180326 Methods and compositions for impairing multiplication of HIV-1
09/25/2003US20030180325 Regulation of apoptosis in aquatic organisms by aquabirnavirus
09/25/2003US20030180317 Diagnosis ear infections in children
09/25/2003US20030180315 Novel proteins in enteroaggregative escherichia coli (EAEC) useful for diagnosis and therapy of EAEC infections
09/25/2003US20030180311 Genetic engineering; binding to antibodies; drugs, medical diagnosis, biosensors
09/25/2003US20030180310 Genetic engineering; binding to antibodies; drugs, medical diagnosis, biosensors
09/25/2003US20030180309 Autoimmune disease; antiinflammatory agents; antiallergens; antihistamines; d
09/25/2003US20030180306 Controlling cell differentiation; muscular disorders
09/25/2003US20030180303 Lipopolysaccharide binding protein derivatives
09/25/2003US20030180302 Genetic engineering
09/25/2003US20030180301 Prevention organ rejection; induction immunology response; reduce fibrosis
09/25/2003US20030180300 Collagen biosynthesis; controlling cell differentiation, cell proliferation
09/25/2003US20030180299 Cardiovascular disorders
09/25/2003US20030180298 Genetic engineering; using nucleic acid for cancer diagnosis
09/25/2003US20030180295 Angiocidin: a Cys-Ser-Val-Thr-Cys-Gly specific tumor cell adhesion receptor
09/25/2003US20030180294 Administering vascular endothelial growth factor receptor inhibitor; supression lymphangiogenesis
09/25/2003US20030180289 Inhibition of secretion from non-neuronal cells
09/25/2003US20030180287 Polypeptide formulation
09/25/2003US20030180286 Antiinflammatory agents; antitumor agents; vascular leakage; hypotensive agents; using nucleic acids
09/25/2003US20030180285 Treatment of fungal infections with polyene or beta glucan synthase inhibitor anti-fungals combined with anti hsp90 antibodies
09/25/2003US20030180284 Monoclonal antibodies; vaccines
09/25/2003US20030180283 Method and apparatus for producing dry particles
09/25/2003US20030180282 Method of treatment of thrombotic events
09/25/2003US20030180281 Preparations for topical skin use and treatment
09/25/2003US20030180280 Calibration deafness therapy; administering mixture of protein and carrier
09/25/2003US20030180279 Composition and method to prevent or reduce diarrhea and steatorrhea in HIV patients
09/25/2003US20030180275 Human serpin polypeptides
09/25/2003US20030180270 Culture product; bone disorders
09/25/2003US20030180265 Modulating angiogenesis
09/25/2003US20030180259 Vascular endothelial growth factor; wound healing agents
09/25/2003US20030180256 Cytokine-like proteins
09/25/2003US20030180255 IL-17 homologous polypeptides and therapeutic uses thereof
09/25/2003US20030180254 Immunologic enhancement with intermittent interleukin-2 therapy
09/25/2003US20030180253 Stabilized liquid polypeptide-containing pharmaceutical compositions
09/25/2003US20030180235 Matrix for preparing microparticles or nanoparticles, method for making said particles and resulting particles
09/25/2003US20030180227 Pharmaceutical formulations for dry powder inhalers in the form of hard-pellets
09/25/2003US20030178029 Method for determining effect of a clostridial toxin upon a muscle
09/25/2003DE19942230C2 Verwendung natriuretischer Peptide als antibiotisch wirksame Subsanzen zur Behandlung von bakteriellen Infektionen Use of natriuretic peptides as effective antibiotic used to treat bacterial infections Subsanzen
09/25/2003CA2518794A1 Compositions and methods for treating emphysema
09/25/2003CA2488928A1 Method of modulating inflammatory response
09/25/2003CA2481399A1 Peptides and pharmaceutical compositions comprising said peptides for treating cancer
09/25/2003CA2479409A1 Double-stranded ribonucleic acid constructs and methods for reducing expression of genes in plants
09/25/2003CA2479246A1 Method for overexpression of zwitterionic polysaccharides
09/25/2003CA2479212A1 Central airway administration for systemic delivery of therapeutics
09/25/2003CA2479118A1 Mutants of the p4 protein of nontypable haemophilus influenzae with reduced enzymatic activity
09/25/2003CA2479042A1 Cartilage regeneration using chondrocyte and tgf-.beta.
09/25/2003CA2479007A1 Cells transfected with a nucleotide sequence encoding glp-1 and secreting insulin in a glucose-dependent manner
09/25/2003CA2478987A1 Method for generating primate trophoblasts
09/25/2003CA2478962A1 Cell surface tropomyosin as a target of angiogenesis inhibition
09/25/2003CA2478762A1 Method for determining effect of a clostridial toxin upon a muscle
09/25/2003CA2478760A1 Use of enzyme inhibitors with aminopeptidase n and/or dipeptidylpeptidase iv activities and pharmaceutical preparations produced therefrom for the therapy and prevention of dermatological diseases with seborrhoeic hyperproliferation and altered differentiation states
09/25/2003CA2478294A1 Gntiii (udp-n-acetylglucosamine:beta-d mannoside beta (1,4)-n-acetylglucosaminyltransferase iii) expression in plants
09/25/2003CA2477909A1 Novel metabolic targets and markers
09/25/2003CA2477832A1 Methods of treating diabetes using pde 11a inhibitors
09/25/2003CA2477604A1 Modulation of protein methylation and phosphoprotein phosphate
09/25/2003CA2463659A1 Compositions and methods for the detection, diagnosis and therapy of hematological malignancies
09/25/2003CA2459836A1 Oligo(ethylene glycol)-terminated 1,2-dithiolanes and their conjugates useful for preparing self-assembled monolayers
09/24/2003EP1347063A1 Multiple genes relevant for the characterisation, diagnosis and manipulation of stroke
1 ... 1765 1766 1767 1768 1769 1770 1771 1772 1773 1774 1775 1776 1777 1778 1779 1780 1781 1782 1783 1784 1785 ... 3163